S06.1 B cell kinetics upon therapy commencement for active extra-renal systemic lupus erythematosus in relation to development of renal flares

S06.1 B cell kinetics upon therapy commencement for active extra-renal systemic lupus erythematosus in relation to development of renal flares

Bibliographic Details
Main Authors:	A Gómez, J Lindblom, I Parodis, C Sjöwall, M Gatto, S Sciascia, JW Chow
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Series:	Lupus Science and Medicine

Similar Items

LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab
by: Brad Rovin, et al.
Published: (2023-07-01)

Early B Cell and Plasma Cell Kinetics Upon Treatment Initiation Portend Flares in Systemic Lupus Erythematosus: A Post-Hoc Analysis of Three Phase III Clinical Trials of Belimumab
by: Ioannis Parodis, et al.
Published: (2022-04-01)

PO.6.119 Low-dose belimumab and antimalarial agents prevent renal flares in systemic lupus erythematosus: results from four randomised clinical trials
by: A Gómez, et al.
Published: (2022-10-01)

P62 Machine learning approaches for prediction of renal flares in systemic lupus erythematosus: knowledge-driven models outperformed data-driven models
by: Ioannis Parodis, et al.
Published: (2024-03-01)

B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools
by: Ioannis Parodis, et al.
Published: (2022-08-01)

PO.2.27 Early changes in the circulating B cell compartment associated with response to treatment and occurrence of flares in patients receiving therapy for active systemic lupus erythematosus
by: A Doria, et al.
Published: (2022-10-01)

LSO-030 Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab
by: Ioannis Parodis, et al.
Published: (2023-07-01)

LP-170 Predictors of neuropsychiatric flares In Patients With Systemic Lupus Erythematosus: Results From Five Phase III clinical trials of belimumab
by: Ioannis Parodis, et al.
Published: (2023-07-01)

B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice
by: Ioannis Parodis, et al.
Published: (2020-07-01)

Early Changes in B and Plasma Cell Subsets and Traditional Serological Markers as Predictors of SRI-4 Response to Therapy in Systemic Lupus Erythematosus
by: Ioannis Parodis, et al.
Published: (2022-04-01)

Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade
by: Julius Lindblom, et al.
Published: (2022-01-01)

Infection-Associated Flares in Systemic Lupus Erythematosus
by: Giuseppe A. Ramirez, et al.
Published: (2024-10-01)

Visceral Leishmaniasis or Systemic Lupus Erythematosus Flare?
by: Sunny Garg, et al.
Published: (2012-01-01)

O28 Unveiling the impact of neuropsychiatric involvement in systemic lupus erythematosus on damage accrual
by: Ioannis Parodis, et al.
Published: (2024-03-01)

Miliary tuberculosis mimicking systemic lupus erythematosus flare
by: Fatehi Elzein, et al.
Published: (2018-01-01)

PO.6.128 Factors associated with survival and discontinuation of antimalarial agents in systemic lupus erythematosus: results from a swedish longitudinal registry
by: I Parodis, et al.
Published: (2022-10-01)

P110 Impact of neuropsychiatric involvement on health-related quality of life in patients with systemic lupus erythematosus
by: Ioannis Parodis, et al.
Published: (2024-03-01)

PO.7.147 Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in patients with systemic lupus erythematosus from a Swedish tertiary referral centre
by: A Gómez, et al.
Published: (2022-10-01)

Prediction of prognosis and renal outcome in lupus nephritis
by: Farah Tamirou, et al.
Published: (2020-10-01)

O11 Unsupervised machine-learning identifies distinct clusters based on B cell phenotyping and autoantibody profiles in patients with systemic lupus erythematosus
by: Andrea Doria, et al.
Published: (2024-03-01)

P61 Harnessing machine learning to predict neuropsychiatric events in systemic lupus erythematosus
by: Ioannis Parodis, et al.
Published: (2024-03-01)

Concurrence of recurrent Wells syndrome and flares of systemic lupus erythematosus
by: Wei-Ting Tu
Published: (2016-03-01)

Correlation Between Systemic Lupus Erythematosus and Renal Damage
by: Elita Zylbeari-Masha, et al.
Published: (2024-02-01)

Holistic approaches in systemic lupus erythematosus: do physicians avoid addressing difficult-to-treat but highly relevant symptoms?
by: Vibeke Strand, et al.
Published: (2025-03-01)

Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus
by: Alexander Borg, et al.
Published: (2023-08-01)

Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus
by: Rangi Kandane-Rathnayake, et al.
Published: (2025-01-01)

Course of Neuropsychiatric Symptoms during Flares of Systemic Lupus Erythematosus (SLE)
by: Gareth Garrett, et al.
Published: (2017-01-01)

Epstein-Barr virus reactivation and disease flare of systemic lupus erythematosus
by: Chung-Jen Chen
Published: (2024-03-01)

Levels of Proteinuria and Renal Pathology in Systemic Lupus Erythematosus Patients
by: Abdurhman Saud Al Arfaj, et al.
Published: (2023-12-01)

Renal involvement in systemic lupus erythematosus: additional histopathological lesions
by: Monique Pereira Rêgo Muniz, et al.
Published: (2020-06-01)

Renal-limited systemic lupus erythematosus: Avoiding delay in diagnosis
by: Inderjot Kaur, et al.
Published: (2023-01-01)

Doplervelocimetria da artéria oftálmica em gestantes portadoras de lúpus eritematoso sistêmico sem atividade de doença renal Ophthalmic artery Doppler in pregnant women with systemic lupus erythematosus without renal disorder flare
by: Márcia Aires Rodrigues de Freitas
Published: (2009-08-01)

Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition
by: Dionysis Nikolopoulos, et al.
Published: (2023-06-01)

Blocking salt‐inducible kinases with YKL‐06‐061 prevents PTZ‐induced seizures in mice
by: Lixuan Peng, et al.
Published: (2023-12-01)

Impact of teleconsultation on subsequent disease activity and flares in patients with systemic lupus erythematosus
by: Au Eong, Jonathan T. W., et al.
Published: (2022)

Prediction of Flares in Systemic Lupus Erythematosus During Post-Remission Follow-up
by: Bai Y, et al.
Published: (2025-03-01)

Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis
by: Oh Chan Kwon, et al.
Published: (2023-02-01)

A rare case of hemophagocytic lymphohistiocytosis mimicking flare of systemic lupus erythematosus
by: Areeb Tiwana, et al.
Published: (2023-05-01)

Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization
by: Young Bin Joo, et al.
Published: (2021-02-01)

Flares and Predicting Factors of Flares in Patients with Systemic Lupus Erythematosus Associated with Different Doses and Types of COVID-19 Vaccines
by: Worawit Louthrenoo, et al.
Published: (2024-12-01)